Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017:2017:3937842.
doi: 10.1155/2017/3937842. Epub 2017 Jun 21.

Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients

Affiliations
Randomized Controlled Trial

Concurrent Aerobic and Resistance Training Has Anti-Inflammatory Effects and Increases Both Plasma and Leukocyte Levels of IGF-1 in Late Middle-Aged Type 2 Diabetic Patients

Giosuè Annibalini et al. Oxid Med Cell Longev. 2017.

Abstract

Type 2 diabetes (T2D) is an age-related chronic disease associated with metabolic dysregulation, chronic inflammation, and activation of peripheral blood mononuclear cells (PBMC). The aim of this study was to assess the effects of a concurrent exercise training program on inflammatory status and metabolic parameters of T2D patients. Sixteen male patients (age range 55-70) were randomly assigned to an intervention group (n = 8), which underwent a concurrent aerobic and resistance training program (3 times a week; 16 weeks), or to a control group, which followed physicians' usual diabetes care advices. Training intervention significantly improved patients' body composition, blood pressure, total cholesterol, and overall fitness level. After training, plasma levels of adipokines leptin (-33.9%) and RBP4 (-21.3%), and proinflammatory markers IL-6 (-25.3%), TNF-α (-19.8%) and MCP-1 (-15.3%) decreased, whereas anabolic hormone IGF-1 level increased (+16.4%). All improvements were significantly greater than those of control patients. Plasma proteomic profile of exercised patients showed a reduction of immunoglobulin K light chain and fibrinogen as well. Training also induced a modulation of IL-6, IGF-1, and IGFBP-3 mRNAs in the PBMCs. These findings confirm that concurrent aerobic and resistance training improves T2D-related metabolic abnormalities and has the potential to reduce the deleterious health effects of diabetes-related inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
2-DE maps of plasma proteins from EXE group before (a) and after (b) the 16-week exercise training program. Differentially expressed spots are indicated by black circles and numbered according to Table 3.
Figure 2
Figure 2
mRNA expression of IL-6, TNF-α, IGF-1, and IGFBP-3 in peripheral monocytes of control (CON) and exercise (EXE) groups at baseline (white bars) and after the 16-week exercise training program (black bars). Values are means ± SD. ∗Significant between-group differences, as assessed by ANCOVA (baseline values as covariates).

References

    1. Donath M. Y., Shoelson S. E. Type 2 diabetes as an inflammatory disease. Nature Reviews. Immunology. 2011;11:98–107. doi: 10.1038/nri2925. - DOI - PubMed
    1. Kalyani R. R., Corriere M., Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. The Lancet Diabetes and Endocrinology. 2014;2:819–829. doi: 10.1016/S2213-8587(14)70034-8. - DOI - PMC - PubMed
    1. Shoelson S. E., Lee J., Goldfine A. B. Inflammation and insulin resistance. The Journal of Clinical Investigation. 2006;116:1793–1801. doi: 10.1172/JCI29069. - DOI - PMC - PubMed
    1. Qatanani M., Lazar M. A. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes & Development. 2007;21:1443–1455. doi: 10.1101/gad.1550907. - DOI - PubMed
    1. Andrade-Oliveira V., Camara N. O., Moraes-Vieira P. M. Adipokines as drug targets in diabetes and underlying disturbances. Journal of Diabetes Research. 2015;2015:11. doi: 10.1155/2015/681612.681612 - DOI - PMC - PubMed

Publication types

Substances